Evidence map›Paper›PMID 29059166›Full record

ArticleOncogene2018

mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma.

B Holmes, A Benavides-Serrato, R S Freeman, K A Landon, T Bashir, R N Nishimura, J Gera

Open access · greenAbstract read
In one paragraph

Article in Oncogene, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Msi2-mediated MiR7a-1 processing repression promotes myogenesis.Journal of cachexia, sarcopenia and muscle · 2022
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

B HolmesDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.ORCID 0000-0002-2768-2991
A Benavides-SerratoDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
R S FreemanDepartment of Research & Development, Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles, CA, USA.
K A LandonDepartment of Research & Development, Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles, CA, USA.
T BashirDepartment of Research & Development, Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles, CA, USA.
R N NishimuraDepartment of Research & Development, Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles, CA, USA.
J GeraDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
University of California, Los Angeles · USVA Greater Los Angeles Healthcare System · US

Funding

Mechanisms of AKT-dependent sensitivity to rapamycinR01CA109312 · NCI · SEPULVEDA RESEARCH CORPORATION · PI GERA, JOSEPH F · 2005 to 2012
$1.6M
Mechanisms of Resistance to mTOR-Targeted TherapiesI01BX002665 · VA · VA GREATER LOS ANGELES HEALTHCARE SYSTEM · PI GERA, JOSEPH F · 2014 to 2025
–
BLRD VA I01 BX002665NCI NIH HHS R01 CA109312
6 · The paper itself

Abstract

Overexpression of Rictor has been demonstrated to result in increased mechanistic target of rapamycin C2 (mTORC2) nucleation and activity leading to tumor growth and increased invasive characteristics in glioblastoma multiforme (GBM). However, the mechanisms regulating Rictor expression in these tumors is not clearly understood. In this report, we demonstrate that Rictor is regulated at the level of mRNA translation via heat-shock transcription factor 1 (HSF1)-induced HuR activity. HuR is shown to directly bind the 3' untranslated region of the Rictor transcript and enhance translational efficiency. Moreover, we demonstrate that mTORC2/AKT signaling activates HSF1 resulting in a feed-forward cascade in which continued mTORC2 activity is able to drive Rictor expression. RNAi-mediated blockade of AKT, HSF1 or HuR is sufficient to downregulate Rictor and inhibit GBM growth and invasive characteristics in vitro and suppress xenograft growth in mice. Modulation of AKT or HSF1 activity via the ectopic expression of mutant alleles support the ability of AKT to activate HSF1 and demonstrate continued HSF1/HuR/Rictor signaling in the context of AKT knockdown. We further show that constitutive overexpression of HuR is able to maintain Rictor expression under conditions of AKT or HSF1 loss. The expression of these components is also examined in patient GBM samples and correlative associations between the relative expression of these factors support the presence of these signaling relationships in GBM. These data support a role for a feed-forward loop mechanism by which mTORC2 activity stimulates Rictor translational efficiency via an AKT/HSF1/HuR signaling cascade resulting in enhanced mTORC2 activity in these tumors.

Indexed as

AnimalsApoptosisBiomarkers, TumorBrain NeoplasmsCell ProliferationELAV-Like Protein 1FemaleFollow-Up StudiesGene Expression Regulation, NeoplasticGlioblastomaHeat Shock Transcription FactorsHumansMechanistic Target of Rapamycin Complex 2MiceMice, SCIDPhosphorylationAKT1 protein, humanBiomarkers, TumorELAVL1 protein, humanELAV-Like Protein 1Heat Shock Transcription FactorsHSF1 protein, humanMechanistic Target of Rapamycin Complex 2Proto-Oncogene Proteins c-aktRapamycin-Insensitive Companion of mTOR ProteinRICTOR protein, human

Identifiers

PMID29059166
PMCPMC5805585
OpenAlexW2950418164

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.